Programme Thesis
The Foresight Fellowship is a year-long, non-monetary fellowship that exists to accelerate early-career scientists, engineers, and builders who are credibly pursuing transformative technology within Foresight's five focus areas: Secure AI, Longevity Biotechnology, Nanotechnology, Neurotechnology, and Existential Hope. The primary value proposition is not a stipend but network capital — introductions to senior researchers, funders, and mentors; paid travel to one technical workshop and one Vision Weekend conference; and seminar membership with presentation rights. The program exists because Foresight believes that providing platform and connectivity early in a researcher's career is a high-leverage multiplier on scientific output, and because the institute needs a pipeline of technically credible voices to animate its events, seminar series, and public communications.
Selection Criteria
- ALIGNMENT (weighted heavily): Work must fall explicitly within one of the five focus areas; Neurotechnology track names three sub-domains verbatim: 'brain-computer interfaces, whole brain emulation, neuro-informed AI' — applicants whose work touches all three have a structural advantage.
- DOMAIN EXPERTISE: Evidence of depth — publications (peer-reviewed or credible preprints), lab placements, or 'notable projects.' Foresight explicitly includes projects alongside publications, which is a meaningful opening for platform builders.
- TECHNICAL EXCELLENCE: The work must be technically feasible with 'clear potential to change the world.' Reviewers appear to weight computational rigor, open-source deliverables, and a demonstrable track record of execution.
- AMBITIOUS VISION: 'Moonshot' framing is explicitly requested — applicants should challenge the status quo and bring genuinely novel ideas, not incremental contributions.
- COMMITMENT TO GROWTH: Demonstrated curiosity, exploration across disciplines, and willingness to push beyond conventional boundaries.
- COMMUNITY FIT (implicit): Fellows present in seminar groups and share career updates with the community — communication ability is implicitly evaluated.
- COHORT SIZE: Approximately 7 neurotechnology fellows per year; total across all tracks ~40–50 (consistent with ~6% acceptance rate).
- NO ELIGIBILITY FLOORS: No explicit degree requirement, nationality restriction, or institutional affiliation requirement in program materials.
Past Winners / Cohort Profiles
Neurotechnology track fellows from 2025–2026 include: Sven Truckenbrodt (MRC Laboratory of Molecular Biology Cambridge — molecular brain mapping, expansion microscopy, co-inventor of PRISM neural barcoding at E11 Bio; also holds an MA in History & Literature); Avery Krieger (Stanford/UPenn systems neuroscientist — whole-brain predictive modeling, neuroprosthetic BCI with collaborators who later founded Neuralink, serial founder of Constellation; science + entrepreneurship dual identity); Elisa Kallioniemi (lab PI at New Jersey Institute of Technology — non-invasive brain stimulation TMS + AI + robotics for individualized therapy); Philip Shiu (whole brain emulations); Constanze Albrecht and Yasmeen Hmaidan also in 2025–2026 neurotech cohort. The dominant archetype is: PhD-level researcher or postdoc/junior PI who is also building tools or companies — not purely academic. Interdisciplinary crossers are welcomed (Truckenbrodt's humanities MA). The cohort skews toward PhD-holders but the program does not formally require one.
Ideal Candidate Fingerprint
The platonic ideal Foresight neurotech fellow is an early-career researcher (PhD candidate, postdoc, or junior PI) who is simultaneously building open-source tools or companies at the intersection of brain-computer interfaces, whole brain emulation, or neuro-informed AI — with at least one peer-reviewed publication or credible preprint, an inspectable GitHub repo, and the ability to give a compelling seminar talk. They have institutional backing but are entrepreneurial enough to have prototyped real software or platforms, and they articulate a genuinely moonshot vision — not incremental improvement but a step toward a fundamentally different understanding of or interface with the brain.
Recommended Framing
Eniola's strongest angle is GATE-first, CCT-as-substrate: lead the application by positioning GATE (open-source BCI neural-stimulation safety evaluation platform, Apache 2.0) as a direct contribution to Foresight's Neurotechnology mission using the program's own verbatim language — 'brain-computer interfaces' and 'neuro-informed AI' — then establish that GATE is scientifically grounded because it rests on a fully specified pharmacological theory (CCT) validated computationally (ODE/RK45 + Bayesian MCMC, 85.8% encoding probability reduction, H1–H5 confirmed) and documented in three sole-authored preprints with endorsement from Harvard (Gershman), Princeton (Daw), Michigan (Berridge), and NYU (Mattar). The narrative arc is full-stack and structurally unusual: independent researcher in Lagos, no institutional lab, no PhD — yet she built a coherent pharmacological framework, proved it computationally, converted it into open-source BCI safety tooling, filed a provisional patent, and assembled an advisory constellation that reads like a top-10 computational neuroscience program. Foresight explicitly prizes moonshots; Eniola's independence is a feature to foreground, not a liability to defend — she is simultaneously the PI, the engineer, and the builder, exactly the scientist+builder archetype that defines the fellowship's most celebrated fellows. TOPOLOGIX (TDA for drug-protein interaction, persistent homology) provides a secondary hook on the Nanotechnology track's 'molecular simulation and modeling software' language if form fields allow.
Watch Out
1. NO PhD / NO INSTITUTIONAL AFFILIATION: Every identifiable past neurotech fellow has a PhD or is completing one and holds a university/lab affiliation. Eniola is B.Pharm-only and listed as 'independent researcher / Lagos / ZYCO.' This is the single largest competitive disadvantage. Counter-framing: invoke Foresight's explicit criterion that 'notable projects' count alongside lab placements; front-load the Harvard/Princeton/Michigan/NYU endorsers in every form section to borrow institutional credibility by proxy.
2. PREPRINTS NOT YET PEER-REVIEWED: CCT papers are on OSF/Zenodo; NBR and Alcohol submissions are listed 'under review.' Reviewers may discount preprint-only status. Mitigation: emphasize the mathematical specification and Bayesian paper's computational completeness (executable, verifiable models, not narrative claims) and cite Gershman's arXiv endorsement as a credibility signal.
3. GEOGRAPHY AND LOGISTICS: Foresight funds travel to one workshop + one Vision Weekend, but AI Nodes (SF/Berlin) assume proximity. Lagos-based applicants face visa friction and time zone friction for ongoing community engagement. Frame remote collaboration capacity and the fact that the entire CCT body of work was co-coordinated with US collaborators remotely.
4. GATE PLATFORM MATURITY: Reviewers will inspect the GitHub repo. If it is sparse or undocumented before the July 31 deadline, the platform-builder credential collapses. Prioritize polishing the README and ensuring computational outputs are visible before submission.
5. COMPETITION INTENSITY: ~7 neurotech slots at ~6% acceptance against a pool dominated by PhD-track researchers at top institutions. The combination of endorser quality, technical stack breadth (ODE + MCMC + TDA + BCI + patent), and the provenance story are genuine differentiators — but this is a long-shot application that requires flawless execution of every form section.